Plasma homocysteine, MTHFR gene mutation, and open-angle glaucoma

Journal of Glaucoma

Volumn 18, Issue 1, 2009, Pages 73-78

  Clement, Colin I ^a,b   Goldberg, Ivan ^a,b,c   Healey, Paul R ^b,c,d   Graham, Stuart L ^b,c  

^a SYDNEY EYE HOSPITAL   (Australia)

^b Eye Associates   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d WESTMEAD HOSPITAL   (Australia)

Author keywords

C677T MTHFR; Homocysteine; Open angle glaucoma

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYTOSINE; HOMOCYSTEINE; THIOURACIL; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; HETEROZYGOSITY; HOMOCYSTEINE BLOOD LEVEL; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; VENOUS BLOOD; BLOOD; EXFOLIATION SYNDROME; FLUORESCENCE POLARIZATION IMMUNOASSAY; GENETICS; INTRAOCULAR PRESSURE; POINT MUTATION; POLYMERASE CHAIN REACTION;

AGED; CROSS-SECTIONAL STUDIES; EXFOLIATION SYNDROME; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; GLAUCOMA, OPEN-ANGLE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INTRAOCULAR PRESSURE; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POINT MUTATION; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES;

EID: 63449097029     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e31816f7631     Document Type: Article

References (30)

1. Flammer J, Orgul S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21:359-393.
2. Lee DJ, Gomez-Marin O, Lam BL, et al. Glaucoma and survival: the national health interview survey 1986-1994. Ophthalmology. 2003;110:1476-1483.
3. Tokunaga T, Kashiwagi K, Tsumura T, et al. Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normal-tension glaucoma. Jpn J Ophthalmol. 2004; 48:380-385.
4. Nygard O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. NEJM. 1997;337:230-236.
5. Perry IJ, Refsum H, Morris RW, et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 1995;346:1395-1398.
6. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. NEJM. 1998;338:1042-1050.
7. Pianka P, Almog Y, Man O, et al. Hyperhomocysteinemia in patients with non-arteritic anterior ischaemic neuropathy, central retinal artery occlusion and central retinal vein occlusion. Ophthalmology. 2000;107:1588-1592.
8. Axer-Siegel R, Bourla D, Ehrlich R, et al. Association of neovascular age-related macular degeneration and hyperhomocysteinemia. Am J Ophthalmol. 2004;137:84-89.
9. Goldstein M, Leibovitch I, Yeffimov I, et al. Hyperhomocys-teinemia in patients with diabetes mellitus with and without diabetic retinopathy. Eye. 2004;18:460-465.
10. Tyagi SC, Lominadze D, Roberts AM. Homocysteine in microvascular endothelial cell barrier permeability. Cell Biochem Biophys. 2005;43:37-44.
11. Moore P, El-sherbeny A, Roon P, et al. Apoptotic cell death in the mouse retinal ganglion cell layer is induced in vivo by the excitatory amino acid homocysteine. Exp Eye Res. 2001;73: 45-57.
12. Bleich S, Junemann A, Von Ahsen N, et al. Homocysteine and risk of open-angle glaucoma. J Neural Transm. 2002;109: 1499-1504.
13. Bleich S, Roedl J, Von Ahsen N, et al. Elevated homocysteine in aqueous humor of patients with pseudoexfoliation glaucoma. Am J Ophthalmol. 2004;138:162-164.
14. Leibovitch I, Kurtz S, Shemesh G, et al. Hyperhomocysteine-mia in pseudoexfoliation glaucoma. J Glaucoma. 2003;12: 36-39.
15. Vessani RM, Ritch R, Liebmann JM, et al. Plasma homocysteine is elevated in patients with exfoliation syndrome. Am J Ophthalmol. 2003;136:41-46.
16. Wang G, Medeiros FA, Barshop BA, et al. Total plasma homocysteine and primary open angle glaucoma. Am J Ophthalmol. 2004;137:401-406.
17. Kang SS, Zhou J, Wong PW. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet. 1988;43:414-421.
18. Junemann AG, von Ahsen N, Reulbach U, et al. C677T variant in the methylenetetrahydrofolate reductase gene is a genetic risk factor for primary open-angle glaucoma. Am J Ophthalmol. 2005;139:721-723.
19. Refsum H, Smith AD, Ueland PM, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem. 2004;50:3-32.
20. Puustjarvi T, Blomster H, Kontkanen M, et al. Plasma and aqueous humour levels of homocysteine in exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol. 2004;242:749-754.
21. Turaçli ME, Tekeli O, Özdemir F, et al. Methylenetetrahydrofolate reductase 677 C-T and homocysteine levels in Turkish patients with pseudoexfoliation. Clin Exp Ophthalmol. 2005;33:505-508.
22. Altinta O, Maral H, Yuksel N, et al. Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma and primary open angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2005;243: 677-683.
23. Cumurcu T, Sahin S, Aydin E. Serum homocysteine, vitamin B12 and folic acid levels in different types of glaucoma. BMC Ophthalmol. 2006;6:6.
24. Roedl JB, Bleich S, Reulbach U, et al. Homocysteine levels in aqueous humor and plasma of patients with primary openangle glaucoma. J Neural Transm. 2007;114:445-450.
25. Al-Delaimy WK, Rexrode KM, Hu FB, et al. Folate intake and risk of stroke among women. Stroke. 2004;35:1259-1263.
26. Mossbock G, Weger M, Faschinger C, et al. Methylenete- trahydrofolatereductase (MTHFR) 677C>T polymorphism and open angle glaucoma. Mol Vis. 2006;12:356-359.
27. Weger M, Stanger O, Deutschmann H, et al. Hyperhomo-cyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion. Ophthalmology. 2002;109:1105-1109.
28. Weger M, Stanger O, Deutschmann H, et al. Hyperhomocyst(e)inaemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy. BJO. 2001;85:803-806.
29. Russo GT, Friso S, Jacques PF, et al. Age and gender affect the relation between methylenetetrahydrofolate reductase C677T genotype and fasting plasma homocysteine concentrations in the Framingham Offspring Study Cohort. J Nutr. 2003;133: 3416-3421.
30. Brown KS, Kluijtmans LA, Young IS, et al. The 5,10- methylenetetrahydrofolate reductase C677T polymorphism interacts with smoking to increase homocysteine. Atherosclerosis. 2004;174:315-322.